Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Science Signaling
|
June 2, 2016
The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes
Lomon So, Jongdae Lee, Miguel Palafox, et al.
International Immunology
|
April 1, 2008
KLF4 is a FOXO target gene that suppresses B cell proliferation
Isharat Yusuf, Michael G Kharas, Jing Chen, et al.
Scientific Reports
|
November 5, 2021
Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition
Thanh-Trang Vo, Lee-Or Herzog, Roberta Buono, et al.
Molecular Cancer Therapeutics
|
June 2, 2017
mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph<sup>+</sup> and Ph-like B-ALL
Thanh-Trang T Vo, J Scott Lee, Duc Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 21, 2008
FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase
Stéphanie Fabre, Florent Carrette, Jing Chen, et al.
The Journal of Clinical Investigation
|
January 10, 2002
Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes
Franck Mauvais-Jarvis, Kohjiro Ueki, David A Fruman, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 8, 2014
DNA-scaffolded multivalent ligands to modulate cell function
Zhiqing Zhang, Mark A Eckert, M Monsur Ali, et al.
Frontiers in Immunology
|
July 18, 2017
The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation
Honyin Chiu, Sharmila Mallya, Phuongthao Nguyen, et al.
The Biochemical Journal
|
July 20, 2011
Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins
Kimberly Romero Rosales, Gurpreet Singh, Kevin Wu, et al.
Blood
|
December 14, 2006
T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling
Jonathan A Deane, Michael G Kharas, Jean S Oak, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Science Signaling
|
June 2, 2016
The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes
Lomon So, Jongdae Lee, Miguel Palafox, et al.
International Immunology
|
April 1, 2008
KLF4 is a FOXO target gene that suppresses B cell proliferation
Isharat Yusuf, Michael G Kharas, Jing Chen, et al.
Scientific Reports
|
November 5, 2021
Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition
Thanh-Trang Vo, Lee-Or Herzog, Roberta Buono, et al.
Molecular Cancer Therapeutics
|
June 2, 2017
mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph<sup>+</sup> and Ph-like B-ALL
Thanh-Trang T Vo, J Scott Lee, Duc Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 21, 2008
FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase
Stéphanie Fabre, Florent Carrette, Jing Chen, et al.
The Journal of Clinical Investigation
|
January 10, 2002
Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes
Franck Mauvais-Jarvis, Kohjiro Ueki, David A Fruman, et al.
Chembiochem : a European Journal of Chemical Biology
|
May 8, 2014
DNA-scaffolded multivalent ligands to modulate cell function
Zhiqing Zhang, Mark A Eckert, M Monsur Ali, et al.
Frontiers in Immunology
|
July 18, 2017
The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation
Honyin Chiu, Sharmila Mallya, Phuongthao Nguyen, et al.
The Biochemical Journal
|
July 20, 2011
Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins
Kimberly Romero Rosales, Gurpreet Singh, Kevin Wu, et al.
Blood
|
December 14, 2006
T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling
Jonathan A Deane, Michael G Kharas, Jean S Oak, et al.
Page
of 11